Search - tctmd.com

Displaying 161 - 169 of 169

Sort: Relevancy | Date

Presentation TCT 2012

The Israeli "Start-up Nation" Approach to Medical Innovation: Defining the Ecosystem

Presenter: Ran Kornowski

October 22, 2012

Presentation TCT 2012

The "Hottest" New Cardiovascular Device Concepts from the Israeli Innovation Pipeline

Presenter: Chaim Lotan

October 22, 2012

Presentation TVT 2012

Israeli Perspectives on Defining the High-Risk Patient Suitable for TAVR

Presenter: Ran Kornowski

June 05, 2012

Presentation

Resultados Clínicos y Tratamiento tras Fracaso de SLF: Ausencia de Factores de Riesgo Tradicionales en la Reestenosis Intra Stent (ISR)

Presenter: G. Maluenda

February 15, 2012

Presentation

Clinical Outcomes and Treatment After DES Failure: The Absence of Traditional Risk Factors for In-Stent Restenosis (ISR)

Presenter: G. Maluenda

February 15, 2012

Presentation TCT 2012

Safety and Efficacy of the Xience Everolimus Eluting Stent Compared to First-Generation Drug-Eluting Stents in Contemporary Clinical Practice.

Presenter: Israel M. Barbash, Rebecca Torgusson, Itsik Ben-Dor, Gabriel Maluenda, Zhenyi Xue, William O. Suddath, Lowell F. Satler, Kenneth M. Kent, Augusto D. Pichard, Ron Waksman

January 03, 2012

Presentation TCT 2012

Safety and Efficacy for the Use of Prasugrel in Patients Undergoing Percutaneous Coronary Intervention and Anticoagulated with Bivalirudin.

Presenter: Ana Laynez, Rebecca Torguson, Camille Hauville, Gabriel Sardi, Itsik Ben-Dor, Gabriel Maluenda, Michael A. Gaglia, Manuel A. Gonzalez, Israel M. Barbash, Zhenyi Xue, William O. Suddath, Lowell F. Satler, Kenneth M. Kent, Augusto D. Pichard, Ron Waksman

January 03, 2012

Presentation TCT 2012

Predictors and Clinical Outcome of Patients with Acute Kidney Injury Following Trans-Cutaneous Aortic Valve Replacement.

Presenter: Israel M. Barbash, Itsik Ben-Dor, Gabriel Maluenda, Paul J. Corso, Steven A. Goldstein, Zuyue Wang, Rebecca Torguson, Lowell F. Satler, Augusto D. Pichard, Ron Waksman

January 03, 2012

Presentation TCT 2012

Does Left Atrial Diameter in Patients with Severe Aortic Stenosis Have a Clinical Impact on Outcome?

Presenter: Camille Hauville, Itsik Ben-Dor, Ana Laynez-Carnicero, Gabriel Sardi, Gabriel Maluenda, Israel M. Barbash, Manuel A. Gonzalez, Michael A. Gaglia, Rebecca Torguson, William O. Suddath, Lowell F. Satler, Kenneth M. Kent, Joseph M. Lindsay, Augusto D. Pichard, Ron Waksman

January 03, 2012

Advertisement

The Israeli "Start-up Nation" Approach to Medical Innovation: Defining the Ecosystem

The "Hottest" New Cardiovascular Device Concepts from the Israeli Innovation Pipeline

Israeli Perspectives on Defining the High-Risk Patient Suitable for TAVR

Resultados Clínicos y Tratamiento tras Fracaso de SLF: Ausencia de Factores de Riesgo Tradicionales en la Reestenosis Intra Stent (ISR)

Clinical Outcomes and Treatment After DES Failure: The Absence of Traditional Risk Factors for In-Stent Restenosis (ISR)

Safety and Efficacy of the Xience Everolimus Eluting Stent Compared to First-Generation Drug-Eluting Stents in Contemporary Clinical Practice.

Safety and Efficacy for the Use of Prasugrel in Patients Undergoing Percutaneous Coronary Intervention and Anticoagulated with Bivalirudin.

Predictors and Clinical Outcome of Patients with Acute Kidney Injury Following Trans-Cutaneous Aortic Valve Replacement.

Does Left Atrial Diameter in Patients with Severe Aortic Stenosis Have a Clinical Impact on Outcome?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content